July 27, 2021 – BD (Becton, Dickinson and Company) (Franklin Lakes, NJ) has acquired Tepha, Inc., a developer and manufacturer of a proprietary resorbable polymer technology.
Tepha’s proprietary resorbable polymer (Poly 4-hydroxybutyric acid, P4HB) technology platform provides additional innovation potential that can accelerate the growth of BD’s surgical mesh portfolio and drives the company into potential new areas within soft tissue repair, reconstruction and regeneration, BD says.
The acquisition of Tepha also provides strategic vertical integration of an important supply chain component for BD’s existing Phasix Mesh products. Tepha’s GalaFLEX portfolio, also based on the novel P4HB polymer, is included in the acquisition.
Tepha’s GalaFLEX products are a bioresorbable scaffold for soft tissue support and to repair, elevate and reinforce deficiencies where weakness or voids exist that require the addition of material to obtain the desired surgical outcome.
The BD Interventional segment intends to expand the applicability of Tepha’s technology to other medical applications and to drive the transformation of soft tissue repair and regeneration as part of its strategy to innovate solutions for clinicians and patients in the future.
Tepha is the sixth tuck-in acquisition that BD has completed in fiscal 2021. The transaction is expected to be immaterial to BD’s fiscal 2021 financial results.
Terms of the transaction were not disclosed.